J&J Gets Ready to Test Ebola Vaccine

The video discusses Johnson & Johnson's efforts to develop an Ebola vaccine, with plans to produce 250,000 doses for clinical trials. The testing has so far been conducted on monkeys, with human trials expected to start in January. The economic implications of vaccine development are highlighted, noting the potential for profit. The video also explores how Ebola news has influenced market trends, with recent positive developments leading to a stock market rally, particularly in healthcare, industrials, and energy sectors.

What is Johnson & Johnson preparing to test?

• A vaccine for Ebola

• A new flu vaccine

• A treatment for malaria

• A cure for the common cold

When are the clinical trials for the Ebola vaccine expected to start?

• May

• January

• December

• August

What is a significant concern regarding the Ebola vaccine development?

• Lack of funding

• Potential side effects

• Delayed production

• Insufficient doses

How did the Ebola situation potentially affect the stock market?

• It had no impact

• It led to a market rally

• It caused a market freeze

• It caused a market crash

Which sector led the stock market rally following the Ebola news?

• Retail

• Healthcare

• Real Estate

• Technology